{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:56:15Z","timestamp":1788350175463,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jbspin.2017.03.013","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T10:37:08Z","timestamp":1493894228000},"page":"311-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study"],"prefix":"10.1016","volume":"85","author":[{"given":"Milka","family":"Maravic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Hincapie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Pilet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Liot\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2017.03.013_bib0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","article-title":"Hyperuricemia starts at 360 micromoles (6mg\/dL)","volume":"82","author":"Bardin","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/acr.22660","article-title":"Prevalence of gout in the adult population of France","volume":"68","author":"Bardin","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/acr.21791","article-title":"Body mass index, obesity and prevalent gout in the United States in 1988\u20131994 and 2007\u20132010","volume":"65","author":"Juraschek","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0030","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for international clinical studies including therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0035","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part I: systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0040","first-page":"783","article-title":"Updated EULAR evidence-based recommendations for the management of gout","volume":"73","author":"Richette","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jbspin.2011.12.006","article-title":"GOSPEL: Prospective survey of gout in France. Part I: design and patient characteristics (n=1003)","volume":"79","author":"Liot\u00e9","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0050","first-page":"630","article-title":"Characteristics and management of gout patients in Europe: data from a large cohort of patients","volume":"19","author":"Richette","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jbspin.2015.10.006","article-title":"GOSPEL 2\u2013Colchicine for the treatment of gout flares in France\u2013GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age","volume":"83","author":"Pascart","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0060","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ijcp.12604","article-title":"Allolpurinol adherence among patients with gout: an Italian general practice database study","volume":"69","author":"Mantarro","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0522-8","article-title":"Epidemiology and management of gout in Taiwan: a nationwide population study","volume":"17","author":"Kuo","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.semarthrit.2015.05.005","article-title":"An open-label, 6 month study of allopurinol safety in gout: the LASSO study","volume":"45","author":"Becker","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0080","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3899\/jrheum.150310","article-title":"An observational study of gout prevalence and quality of care in a national Australian general practice population","volume":"42","author":"Robinson","year":"2015","journal-title":"J Rheumatol First Release"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0090","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study","volume":"72","author":"Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/annrheumdis-2013-203226","article-title":"Managing gout needs more than drugs: \u2018Il faut le savoir-faire, l\u2019Art et la mani\u00e8re\u2019","volume":"72","author":"Liot\u00e9","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"Phillips","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2474-12-7","article-title":"Management of osteoporosis and associated quality of life in post menopausal women","volume":"12","author":"Cortet","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0110","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0115","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.03.013_bib0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.diabet.2013.12.009","article-title":"Clinical inertia, uncertainty and individualized guidelines","volume":"40","author":"Reach","year":"2014","journal-title":"Diabetes Metab"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17300854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17300854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T04:50:04Z","timestamp":1535863804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X17300854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1297319X17300854"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.03.013","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}